Filiz Güldaval

Which one is superior in predicting 30 and 90 days mortality after COPD exacerbation: DECAF, CURB-65, PSI, BAP-65, PLR, NLR

Mine Gayaf, Gülistan Karadeniz, Filiz Güldaval et al. · Expert Review of Respiratory Medicine · 2021 · 16 citations

Medicine, Clinical Sciences, Internal Medicine +17

Quantitative CT in mortality prediction in pulmonary fibrosis with or without emphysema.

Fatma Demirci Üçsular, Gülistan Karadeniz, Gülru Polat et al. · PubMed · 2021 · 15 citations · Full text

Medicine, Clinical Sciences, Radiology +17

Contribution of cell block obtained by thoracentesis in the diagnosis of malignant pleural effusion

Ceyda Anar, Filiz Güldaval, Gülru Polat et al. · Journal of Cytology · 2019 · 12 citations · Full text

Medicine, Oncology, Pathology +15

What are the Differences Between Smoker and Non-smoker COPD Cases? Is it a Different Phenotype?

Filiz Güldaval, Gülru Polat, Sibel Doruk et al. · Turkish Thoracic Journal · 2021 · 12 citations · Full text

Medicine, Preventive Medicine, Environmental Health +13

Regional distribution of genetic mutation in lung cancer in Turkey (REDIGMA)

Neslihan Özçelik, Nimet Aksel, Yılmaz Bülbül et al. · Tuberkuloz ve Toraks · 2019 · 11 citations · Full text

Medicine, Genetics, Oncology +17